Review

Tackling the global health threat of arboviruses: An appraisal of the three holistic approaches to health

Introduction

The emergence and re-emergence of arthropod-borne viruses otherwise known as arboviruses is a public health threat across the globe causing an increased infection to humans and animals, thus, resulting in a large socio-economic burden. As reported by the World Health Organization (WHO), vector-borne diseases (VBDs) including arboviruses account for ~17% of infectious diseases and about 700 000 deaths per annum worldwide. ¹ For transmission to occur, arboviruses require arthropod vectors such as mosquitoes, sandflies, and ticks to allow for their replication before transmission to their vertebrate host – mostly humans and animals. ² Arboviruses undergo series of cycles such as sylvatic or enzootic cycle where disease transmission occurs between wild animals serving as the reservoir host and the arthropod vectors, this has the tendency of increased viral amplification in the host with humans as the dead-end host through spillover. ^2,3 Epizootic cycle involves the transmission of diseases between domestic animals and arthropod vectors and has the potential of causing an epidemic in the animal population; humans get infected during contact with infected animals. ^2,3 Arboviruses also undergo an urban cycle where humans are the amplifying host as well as the source of infections causing an epidemic in the urban area. ³ Infections posed by arboviruses to humans and animals are concentrated in four families which are Togaviridae, Flaviviridae, Bunyaviridae,and Reoviridae. ⁴ However, increased arboviral infections are caused as a result of increased geographical distribution and abundance of arthropod vectors especially the species of Aedes (Aedes aegyptiand Aedes albopictus) and Culex(Culex tarsalis, Culex quinquefasciatus, Culex pipiens) mosquitoes known to transmit medically-important arboviral diseases such as West Nile viruses (WNVs), yellow fever viruses (YFVs), Chikungunya viruses (CHIKVs), and dengue viruses (DENVs). ⁵ Other prevalent vectors such as sandflies, ticks, and Culicoides are associated with the transmission of arboviruses. ⁵ Consequently, the spread of arboviruses is on the rise in an era pronounced as Anthropocene (a recently proposed epoch in the geological time scale and the era of humans), and this is closely tied to concurring factors including migration, urbanization, climate change, and others affecting the viral agent, the human host, and the environment. ⁶ In a bid to safeguard human health against public health threats i.e. emerging and reemerging infectious diseases, several holistic approaches like One Health, Eco-Health, and Planetary Health have been developed and adopted by the global health communities. This article, therefore, highlights arboviruses as a global health threat, explicates some important arboviral diseases and factors facilitating their spread, and finally appraised the three relevant holistic approaches as a possible way forward.

Materials and Methods

We conducted a narrative review in search of relevant articles published in English on arboviruses and holistic approaches from 1990 to 2021. In our search, we considered a number of databases and search engines including Medline, PubMed, WHO, Scopus, Science Direct, DOAJ, AJOL, and Google Scholar to identify relevant articles using the following keywords and search terms; “arboviral diseases”, “arbovirus vectors”, “arboviral infections”, “epidemiology of arboviruses”, “holistic approaches”, “One Health”, “Eco-Health”, and “Planetary Health”. Relevant articles including epidemiological and clinical studies of arboviruses were critically accessed for initial eligibility in line with our study. Studies that were evaluated and appraised depict the association and relationship between arboviruses and one or more of the holistic approaches to health including One Health, Planetary Health and EcoHealth.

Important arboviral diseases

West Nile fever

WNV is a mosquito-borne flavivirus in the Japanese encephalitis serogroup and belongs to the Flaviviridae family. ² Since the first case of the virus was reported in Uganda in 1937, it has continued to spread across different parts of the world including Israel, Russia, the United State of America, and Romania where the largest epidemic has occurred. ^7,8 Through an enzootic transmission cycle, the virus is transmitted between Culex mosquitoes – the principal vectors of the virus – and birds – the reservoir hosts, and humans are just accidental hosts when spillovers occur during an outbreak in the animals’ population. ² In the urban transmission cycle, human infections can also occur through the bite of infected Culexmosquitoes transmitting the virus. ⁹ Changes in climate factors (temperature, precipitation, humidity) and other human factors like migration, land-use change, and urbanization played an important role in the dissemination of WNV which have been documented in various studies. ^10-14 Temperature as an important climatic factor is closely linked with the distribution of Culexmosquitoes which are sensitive to even a little change in ambient temperature. In their study, Kilpatrick and colleagues reported that increased temperatures accelerate the frequency of mosquito bites and viral replication rate of WNV in vectors, which in turn lead to a high rate of WNV infections. ¹² Migration of people between countries as a result of trade and travel has led to the introduction of important mosquito vectors of WNV including C. pipiens and C. quinquefasciatus between countries. ¹⁴ Prevalence of C. pipiens and C. tarsalis, the two most important WNV mosquito vectors in eastern and western North America, are associated with increased anthropogenic land-use change, urbanization, and intensified agricultural practices. ^15,16 To date, the human-to-human transmission via contact of the virus has neither been reported nor documented and a human vaccine against the virus is yet to be developed. Cases of arbovirus infection being misdiagnosed and treated like other diseases such as malaria, hepatitis, measles, and coronavirus diseases 2019 (COVID-19) have been reported. ^17-22 In a study by Schiuma and colleagues, WNV infection being misdiagnosed for COVID-19 in an Egyptian woman has been reported. ²²

Zika

Zika virus (ZIKV) is another mosquito-borne flavivirus that belongs to the family Flaviviridae. ²³ The virus was first discovered from the serum of sentinel monkeys in 1947 and is named after a forest – Zika – in Uganda where the monkey was found. ²⁴ The following year, the virus was also discovered from Aedesmosquitoes in the same forest and thus, it can be concluded that the virus has its origin in Africa. The virus is transmitted by Aedes mosquito vector species including Ae. albopictus, Ae. hensilli, Ae. poliniensis, and Ae. aegypti—the principal vector of WNV associated with urban transmission. ²⁵ The first human case of infection was discovered in a Nigerian lady and since then, it has continued to spread at an alarming rate to different regions of African countries thereby causing an epidemic. ^26,27 However, the epidemic of the virus has also been reported outside the African region such as USA, Asia, and French Polynesia where it poses a significant threat to human health. ^28,29 Increased temperature favors the activities (fecundity, survival, biting, and competence) of Ae. aegypti and this has been associated with the emergence of ZIKV in Americas during the summer period in both tropical and subtropical regions of the country. ³⁰ Anthropogenic human activities like urbanization and land-use change that could result in decreased land cover have been linked with increased Ae. aegyptiactivities and transmission of ZIKV infections. ³⁰ Consequently, migration of infected people and trading of old used tires between countries are associated with increased ZIKV infections. ³¹ Medical factors such as misdiagnosis also occur in ZIKV as reported by Oidtman and colleagues in a study where ZIKV was misdiagnosed for CHIKV or Dengue across the Americas and has thus led to the underestimation of ZIKV epidemic that occurred in 2015-2017. ³²

Chikungunya

CHIKV is an Alphavirus that belongs to the Togaviridae family. ³³ The virus which has its origin in the eastern half of Africa is widely transmitted throughout the world by Ae. aegyptiand Ae. albopictus thereby causing epidemics. ³³ However, studies have shown that the virus circulates rapidly in the enzootic cycle among the non-human primates through Aedes vectors while humans may be an accidental host through the bite of Ae. albopictus, the main vector implicated in the spread to humans. ³⁴ The virus also undergoes sylvatic transmission cycle between arboreal mosquitoes and wild primates, and this has been reported in Africa. ² In 1952, the epidemic of the virus occurred in Tanzania and was reported as the first diagnosed case of CHIKV. ³⁵ Since the first epidemic, several other outbreaks have been reported in Africa and South East Asia where transmission of the virus occurred through the urban cycle involving the mosquito vectors and the human host. ^36,37 An increased epidemic of CHIKV has been associated with its genetic mutation facilitating multiplication within the midgut of Aedes mosquito vectors. ³⁷ Climatic factors are also associated with the epidemics of CHIKV, as an increased temperature has been linked with its first outbreaks in Italy. ^38,39 Consequently, heavy rainfall from increased precipitation was linked with increased transmission of CHIKV in France in 2014 as a result of an abundance of Ae. albopictus. ⁴⁰ Cases of misdiagnosis of CHIKV for other arboviral diseases occur and have been discussed in several pieces of scientific literature. ^41,42

Japanese encephalitis

Japanese encephalitis virus (JEV) is a Flavivirus of the Flaviviridae family widely distributed across the world and causing a public health threat. ⁴³ The virus is transmitted by Culex tritaeniorhynchusand C. pipiens. In the enzootic cycle, the virus is transmitted between Culex mosquitoes and vertebrate species like aquatic birds and pigs, while humans and equids are the dead-end hosts. ⁴⁴ Humans become infected through the bite of infected C. tritaeniorhynchus when the virus is amplified in the domestic cycle by pigs due to their proximity to human habitat as elucidated in a study by Yun and colleagues. ⁴⁵ Histologically, the first confirmed case of the virus was reported in Japan in 1924 and since then, cases have been confirmed in other countries such as India, the Philippines, Korea, and other parts of the world but particularly the Asian countries. ^43,46 However, the virus is endemic in some parts of Asia as a result of increased population and intensified rice farming cultivation facilitating the spread of Culex mosquito vectors. ⁴⁷ In a study by Preziuso and colleagues, JEV has been detected in the bone marrow of migratory wild birds in Italy suspected to be due to the migration of the bird from Asia – where the virus is endemic – to Europe. ⁴⁸ In their study, Hsu and colleagues established a positive correlation of climatic factors (temperature and precipitation) with the increased spread of JEV. ⁴⁹ A decrease in temperature as a result of lower rainfall has led to a decrease in C. tritaeniorhynchusmosquito in 1980-1981 in a study in China. ⁴⁹ Consequently, medical factors like misdiagnosis also occur in JEV as reported in various studies. ⁵⁰

Yellow fever

YFV is a mosquito-borne flavivirus propagated mainly by the Aedes species of mosquitoes, and sometimes the Haemagogus sp. and the Sabethessp.—found mostly in forested areas. ⁵¹ Yellow fever is endemic to 47 countries in Africa, and Central and South America. ⁵² Angola including the Democratic Republic of the Congo (DRC) experienced large outbreaks of yellow fever in 2015 and 2016 while Brazil and Nigeria followed in 2017 and 2018 respectively. ⁵² Higher cases have been recorded in Brazil due to the expansion of the epizootic endemic areas to places close to Rio de Janeiro and São Paulo – two of the major cities in the country. ⁵³ Yellow fever outbreaks continue to occur in Africa, affecting both rural and urban populations, and in South America. Infection by the Haemagogus sp.and the Sabethessp affect mostly male humans and it is suspected to have started with men who entered forested areas for work or recreation as associated with recent outbreaks. Ae. aegypti, the species causing infection in the urban communities of tropical and subtropical South America, has not been documented in recent outbreaks, ⁵⁴ the last urban outbreak in Brazil being in 1942. The virus genomes recognized from the South America outbreak in December 2016 further proved that infection was due to forest YFV spilling over into human populations, and this caused more than 2000 human cases and more than 700 deaths in Brazil alone within 2 years, graduating into the largest epidemic in Brazil for decades. ⁵⁵ Climatic and other environmental factors have been associated with the spread of YFV and this has appeared in various scientific studies. ^56-58 Misdiagnosis of YFV has also been reported. ⁵⁸

Dengue fever

Dengue fever (DF) is the fastest spreading mosquito-borne viral infection and is caused by the dengue virus (DENV), a flavivirus of the Flaviviridae family. ⁵⁹ DF is considered an important health challenge in 128 countries ^60-63 in the tropic and subtropic nations ⁶⁴ with an estimate of 3.97 billion people residing in dengue-endemic regions ⁶⁵ and about 400 million infections recorded per year. ^66-69 The Indian subcontinent has been identified as the center of DF ⁷⁰ and having a highly underestimated number of cases. ⁷¹ The first reported case of a dengue-like illness in India was in 1780, but there was no proven case until the 1963 epidemic. ⁷² Countries in Africa such as Angola, Benin, Burkina Faso, Cape Verde, Comoros, Egypt, Ivory Coast, Kenya, Nigeria, Somalia, Tanzania, and Zanzibar have suffered dengue epidemics since 2010 ^73,74 ; with sporadic DENV outbreaks having been reported in Nigeria since 1960. ⁷⁵ The virus is widely distributed, not only in the urban environment but also in the forest areas of the tropical, subtropical and temperate regions of the world through two important species of the Aedes mosquito vectors (Ae. aegyptiand Ae. albopictus). ⁷⁶ Humans are the reservoir and amplifying host of the virus and usually got infected through the bites of Aedes mosquitoes. ⁷⁶ Various climatic factors such as temperature, precipitation, as well as other factors like urbanization and migration have been linked with the distribution of Aedes mosquitoes which in turn facilitate the spread of dengue. ^77-79 Misdiagnosis of the virus has also been reported. ⁸⁰

Factors associated with the spread of arboviral diseases

Error in classification and diagnosis

In Sudan and other parts of Africa, misclassification and misdiagnosis are major challenges associated with the spread of arboviruses. This is due to the likeness of symptoms and signs between arboviral diseases and other local infectious diseases, e.g. malaria, hepatitis, measles, etc. ^17-21 Also included are the unavailability of specified health policies for the prevention and control of these diseases, ⁸¹ almost non-existent diagnostic power, ^20,82,83 and the fact that health funds are mainly diverted to preventing and treating malaria in malaria-endemic countries and territories. ⁸⁴

Climatic factors

Climatic factors such as temperature, humidity, and precipitation encourage the growth, survival, and dispersal of JEV mosquito vectors. ^10,85,86 In Asian countries such as China, Japanese encephalitis has an established pattern that varies with the season in humans. There is always an increase in the number of cases from June which goes on to and heightens in August, continues till September when it starts to decrease. ^86,87 In India, also, there is a recorded relationship between temperature and mosquito density in areas that are endemic to JEV, showing optimal temperatures for the vectors to lie between 22.8-34.5^oC. ^88,89 The higher the temperature, the higher the development and survival rate of mosquito larvae in the cold, and the shorter the incubation period for replication in mosquitoes, and also the time between blood meals. Hence, the reduction in time for transmission from the mosquito vector to animal and human hosts. ⁹⁰ Therefore, higher temperatures give way to the rapid increase in mosquito populations to reach large population sizes, which then facilitates JEV transmission. ^91,92

However, the correlations with precipitation, density, and temperature are not always linear and this can be seen in the WNV. ^10,93 Examples are laboratory studies that have shown that the infection and transmission rates in WNV increase with temperature in some mosquito types but not in others, ⁹⁴ and that some strains of some viruses are transmitted better in higher temperatures than others. ⁹⁵ Also, the precipitation effect of the epidemiology of WNV differs with regions and is likely dependable on the species and lineage of the vector. ⁹³

As for the Rift Valley fever virus, epidemics usually break out after heavy rainfall and flooding leading to the creation of temporary mosquito breeding pools that allow for the breeding of mosquitoes into large numbers. ^10,96-101 Still, some previous outbreaks in some parts of Africa were not associated with heavy rainfall, neither do they occur during droughts. ^102,103 As with all and other mosquito-borne viruses, temperature also plays a very great role in the ecology of Rift Valley fever virus. ^101,104,105 Temperatures from 17-35°C allow the increase of mosquito populations, enabling them to reach large population sizes for longer periods, ^76,106 facilitating replication and transmission in Culex spp ¹⁰⁷ and Aedes spp ¹⁰⁸ mosquitoes.

Migration

According to the United Nations prediction, the global population tends to increase from its currently >7 billion population to about 9.6 billion by 2050. ¹⁰⁹ The major consequence of this population increase is the ability to facilitate the increased transmission of vectors and the viruses they are transmitting. As the global population increases, a large number of people tends to change their location by way of migration thus facilitating the spread of viruses directly from person-person or through vectors. Consequently, while most arboviral diseases are endemic to the areas where they are recorded, others found their way there via several means ranging from the slave trade to migration of birds and livestock, and mobility of humans from the endemic countries to countries where the viruses are novel: YFV and DENV to the Americas, CHIKV to the New World and Polynesia; yet others reemerged or were reintroduced after previously being eradicated. ¹¹⁰

Abundance in propagative vectors

The availability of different species and types of vectors able to transmit arboviruses plays an important role in their rapid transmission and difficult eradication, prevention, control, and treatment. 300 types of mosquitoes (mainly Aedes spp. and Culex spp.), ¹¹¹ 116 types of ticks, 25 species of midges (majorlyCulicoides spp. and Lasioheleaspp.), bedbugs, mites, stinkbugs,sandflies, gadfly, lice, blackflies, etc, ¹¹² all aid the propagation of arboviruses. ^2,111,113 Also, some arboviruses known to be transmitted by a specific type of vector are transmitted by others. For example, WNV is known to be mosquito-borne, but its propagation and transmission via ticks and other arthropods have been recorded. ^2,111,114 Also, JEV can be transmitted by Culex, Anopheles, other mosquito species, midges, sandflies, and ticks. ¹¹⁵

Urbanization

Overpopulation of urban areas, migration of humans, the establishment of settlements, human activities, etc. all contribute to the emergence and reemergence of most arboviruses. As vectors need breeding grounds – mostly standing water – as well as hosts – humans and animals – these requirements are satisfied where there is human inhabitation, and even better if the population is high. Examples of arboviruses implicated in this are DENV ¹¹⁶ and WNV. ^11,117-119

Changes in land use

This has been linked with loss of vectors’ and host’s habitats which affect their distribution patterns including their behavioral changes, as vectors tend to search for new breeding sites and habitats. There is a relationship between the spread of JEV and WNV and rice farming, pig farming, poultry farming, etc. ^11,120-122

Holistic approaches as a panacea: Planetary Health, One Health, and EcoHealth

Newly emerging and re-emerging arboviral diseases such as yellow fever, Zika, and Chikungunya continue to pose a public health threat to the human populations owing largely to their distributions which are greatly affected by environmental, societal, and human-associated factors. ^76,123-125 Over the years, several strategies including biological, chemical, and physical control ¹²⁶ have been adopted on VBDs but most have failed while the prevalence of arboviruses persists, this is evident from the recent epidemic outbreak of ZIKV throughout the United States in 2016, ¹²⁷ and the Jaipur city of India in 2018. ¹²⁸ However, coping with emerging and re-emerging arboviral disease epidemics requires the adoption of a holistic approach that works with the vector-host-environment interface, involving experts from interrelated fields to perform transdisciplinary and evidence-based research aimed at promoting VBDs prevention, surveillance, management, and control. It is pertinent to note that several holistic approaches exist on health security against public health threat, and the most relevant ones are Planetary Health, One Health, and EcoHealth. ¹²⁹ Of these three, the first is a new concept and appears to encapsulate the other two. The appraisal of the holistic approaches to health towards improving arboviral disease control have been summarized in Table 1.

Planetary Health

Since global climate changes caused by anthropogenic activities are an important driver of VBDs, ^130,131 the adoption of a planetary health approach could be the best strategy that can make us see the connection between our health and the environment, thereby helping to cope with the emergence of arboviruses. The Rockefeller Foundation-LancetCommission clearly defined planetary health in their article published in 2015 as: “the achievement of the highest attainable standard of health, wellbeing, and equity worldwide through judicious attention to the human systems – political, economic, and social – that shape the future of humanity and the Earth’s natural systems that define the safe environmental limits within which humanity can flourish”. ¹³² From this definition, it is apparent that the planetary health approach aims to mitigate and address the diverse effects of environmental health threats faced by humans to achieve optimal health and well-being. ¹³² Planetary Health is a novel concept developed by the Rockefeller Foundation in 2015 to understand the effects of global environmental changes on earth’s natural systems, and how these effects affect human health and well-being at different levels, ¹³³ this concept extends to understand the influence of global climate change and temperature on the distribution of emerging infectious diseases outbreaks to ensure a sustainable environment for future generations to thrive mentally and physically. ⁶⁰

Planetary Health as a panacea to arboviral diseases

The Planetary Health concept can be adopted by the global communities in response to the emerging and re-emerging VBDs in the following ways:

Well-coordinated interdisciplinary entomological surveillance and vector control monitoring should be implemented for early detection and prompt response to emerging arboviral diseases. ^61,62 Adopting a Planetary Health approach will be of great benefit in tackling the emergence of VBDs particularly in resource-limited settings including the developing African countries as it allows intersectoral collaboration leading to cost-resource sharing amongst translational fields within the concerned ministries.

There should be an integrated national reference laboratory across each country involving expertise collaboration to share ideas and step-by-step procedures on the diagnosis of arboviral diseases, interpretation of results, and data sharing. ⁶³ This will ensure quality data are presented for adequate national treatment guidelines.

National policy and regional frameworks aimed at integrating vector control and surveillance in the health systems across the countries should be implemented. ¹³⁴ This would enhance preparedness and response to outbreaks of VBDs.

Planetary Health as a novel approach requires huge funding for implementation, ^38,135 and thereby requires support from the government and policymakers through partnership and engagement with Planetary Health stakeholders to facilitate the management, control, and response to arboviral diseases.

One Health

One Health has been described as a concept that aims to understand the interconnections that exist between humans, animals, plants, and their shared environments to optimize their health through interdisciplinary and intersectoral collaborations amongst expertise at the global, regional, national, and local level. ¹³⁶ This concept, therefore, tends to safeguard the health of humans, animals, and the environment by addressing the public health threats occurring at their shared interface. ¹³⁷ The One Health concept is one of the oldest of the three concepts and the history dates back to 1980s when scientists underline the need to tackle and protect the health of humans and animals from global health threats of infectious diseases such as VBDs and zoonoses. ¹³⁸ In the fight against VBDs, the One Health concept can be adopted by the global communities as a mitigating strategy for arboviruses.

One Health as a Panacea to arboviral diseases

The rise and spread of arboviral diseases threaten the global communities including the developed, developing, and underdeveloped countries. ^{36,76,106,123} However, adopting the One Health concept can be the best control and mitigation strategy for the emerging arboviral diseases in the following ways:

An interdisciplinary coordinated VBDs surveillance and monitoring of local vectors of arboviruses should be conducted; this is to understand the pattern of spread and transmission of arboviral diseases.

Since there are challenges with the diagnosis of arboviral diseases such as misdiagnosis and indistinguishable infection symptoms due to the co-circulation of arboviruses, there should be an availability of a national reference laboratory for arboviral diseases where differential diagnosis and specific serological tests for seroprevalence studies would be performed. ⁷⁶ This should involve the collaboration of relevant expertise to share ideas, knowledge, and skills for effective confirmation of arboviral diseases on time.

One Health-based research on arboviral diseases should be prioritized amongst researchers particularly on factors determining the transmission and infections of VBDs, surveillance systems, development of effective control therapy including antiviral drugs and vaccines. ⁷⁶

There is a need for assessment and evaluation of existing interventions, policies, and frameworks for arboviruses control. This is to ensure appropriate and up-to-date contingency plans for arboviral disease epidemics.

EcoHealth

EcoHealth is an interdisciplinary systems-based concept aimed at promoting the health of humans, animals, and ecosystems but focusing more on ecological and socio-economic stability. ¹³⁹ Waltner-Toews, ¹⁴⁰ in his review, suggested that the primary aim of EcoHealth is to ensure the sustainable health of humans and animals through a flourishing ecosystem. This old concept has a more focus on the effect of biodiversity conditions on emerging infectious diseases with a view that zoonotic pathogens and VBDs are of wildlife origin. ^129,139,140 It, therefore, seeks to reduce and address the health crises in humans, animals, and the environment caused as a result of ecological disruptions, particularly the loss of biodiversity due to anthropogenic activities. Since arboviral diseases have a biodiversity origin, the adoption of an EcoHealth concept could be the best strategy for control.

EcoHealth as a Panacea to arboviral diseases

Due to the prevalence of arboviral diseases, it is essential to prevent the transmission of pathogens by vectors, and this can be achieved through the adoption of the EcoHealth concept in the following ways:

An interdisciplinary and intersectoral collaboration amongst expertise and relevant ministries aimed at environmental management should be performed. ⁷⁶ This includes the elimination of the natural breeding site of vectors, adoption of good environmental sanitation practices that reduce human-vector contact, increased advocacy to people on the use of insecticide-treated bed nets. ^76,141

Existing policies and interventions on vector control should be evaluated and screened while new models and policies approach such as the use of genetic engineering techniques like CRISPR-Cas9 that allows targeted modification and transformation of vectors’ genes could be the way to reduce vector populations. ¹⁴²

Advocacy to the population and training of physicians on VBDs control should be carried out at the local and national levels. ³⁶ This will enable individuals to be enlightened on the best control strategies for VBDs, at the same time physicians should be equipped with the latest skills and methodologies of arboviral disease control. ³⁶

Vector control programs and VBDs surveillance supported by the government should be carried out regularly, while antiviral drugs, vaccines, and diagnostic tools should be made available in the national healthcare sector. This will increase the national health capacity response to arboviral diseases control (Table 1).

Conclusion

The geographical distribution of arboviruses being facilitated by changes in climatic, environmental, and socio-economic conditions is a public health threat across the globe. To safeguard the health of humans and that of animals from the risk of infections posed by arboviruses, several holistic approaches have been developed. However, the three most relevant are One Health, Eco-Health, and Planetary Health – these approaches have a lot in common because of their sole aim in protecting the health of humans, animals, and their shared environment from any known public health threat. However, there are also some differences in their core values which may affect their method of application to solving a public health threat. In this review, we have highlighted arboviruses as a global public health threat and explicated some factors facilitating their geographical distribution. Consequently, considering the interconnection that exists between the health of humans, animals, and their shared environment, we appraised the approaches as a way forward to mitigate the public health threat of arboviruses. This review was consciously prepared without being sentimental or prioritizing an approach over the other as we finally conclude that either of these approaches can be adopted on arboviral diseases control or a combination of any two.

Acknowledgements

The authors appreciate Dr. Habiba Atta and the reviewers for their insightful comments in improving the quality of this manuscript. YAT and IOO also extend their appreciation to the Africa Community of Planetary Partners for Health and Environment (ACOPPHE)’s Mentoring Research Network whom they have gained a lot of inspiration and knowledge from, through experiential learning and meaningful academic conversations in the fields of One Health, EcoHealth, and Planetary Health.

Funding

None.

Competing Interests

None.

Ethical Approval

Not applicable.

Authors’ contributions

The concept for this review was developed by YAT and IOO. YAT, IOO, MOM and STM developed the draft and prepared the manuscript. YAT, IOO and NTA assisted with data collection, article interpretation, and language edits. All the authors have read and agreed to the final manuscript.

References

1. World Health Organization. Vector-borne diseases. Available from: https://www.who.int/news-room/fact-sheets/detail/vector-borne-diseases. Accessed May 11, 2021.
2. Weaver SC, Reisen WK. Present and future arboviral threats. Antiviral Res 2010; 85(2):328-45. doi: 10.1016/j.antiviral.2009.10.008 [Crossref]
3. Agarwal A, Parida M, Dash PK. Impact of transmission cycles and vector competence on global expansion and emergence of arboviruses. Rev Med Virol 2017; 27(5):e1941. doi: 10.1002/rmv.1941 [Crossref]
4. Ketkar H, Herman D, Wang P. Genetic determinants of the re-emergence of arboviral diseases. Viruses 2019; 11(2):150. doi: 10.3390/v11020150 [Crossref]
5. Gubler DJ. The global threat of emergent/re-emergent vector-borne diseases. In: Atkinson PW, ed. Vector Biology, Ecology and Control. Dordrecht: Springer; 2010. p. 39-62. 10.1007/978-90-481-2458-9_4
6. Institute of Medicine (IOM). Emerging Viral Diseases: The One Health Connection. Washington, DC: The National Academies Press; 2015. Available from: http://www.ncbi.nlm.nih.gov/books/NBK280057/. Accessed June 23, 2021.
7. Smithburn KC, Hughes TP, Burke AW, Paul JH. A neurotropic virus isolated from the blood of a native of Uganda. Am J Trop Med Hyg 1940; 1(4):471-92. doi: 10.4269/ajtmh.1940.s1-20.471 [Crossref]
8. World Health Organization (2017). West Nile Virus. Available from: https://www.who.int/news-room/fac-sheets/detail/west-nile-virus. Accessed June 6, 2021.
9. Kilpatrick AM, Meola MA, Moudy RM, Kramer LD. Temperature, viral genetics, and the transmission of West Nile virus by Culex pipiens mosquitoes. PLoS Pathog 2008; 4(6):e1000092. doi: 10.1371/journal.ppat.1000092 [Crossref]
10. Esser HJ, Mögling R, Cleton NB, van der Jeugd H, Sprong H, Stroo A. Risk factors associated with sustained circulation of six zoonotic arboviruses: a systematic review for selection of surveillance sites in non-endemic areas. Parasit Vectors 2019; 12(1):265. doi: 10.1186/s13071-019-3515-7 [Crossref]
11. Gubler DJ. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res 2002; 33(4):330-42. doi: 10.1016/s0188-4409(02)00378-8 [Crossref]
12. Stilianakis NI, Syrris V, Petroliagkis T, Pärt P, Gewehr S, Kalaitzopoulou S. Identification of climatic factors affecting the epidemiology of human West Nile virus infections in northern Greece. PLoS One 2016; 11(9):e0161510. doi: 10.1371/journal.pone.0161510 [Crossref]
13. Chung WM, Buseman CM, Joyner SN, Hughes SM, Fomby TB, Luby JP. The 2012 West Nile encephalitis epidemic in Dallas, Texas. JAMA 2013; 310(3):297-307. doi: 10.1001/jama.2013.8267 [Crossref]
14. Lounibos LP. Invasions by insect vectors of human disease. Annu Rev Entomol 2002; 47:233-66. doi: 10.1146/annurev.ento.47.091201.145206 [Crossref]
15. Bowden SE, Magori K, Drake JM. Regional differences in the association between land cover and West Nile virus disease incidence in humans in the United States. Am J Trop Med Hyg 2011; 84(2):234-8. doi: 10.4269/ajtmh.2011.10-0134 [Crossref]
16. DeGroote JP, Sugumaran R. National and regional associations between human West Nile virus incidence and demographic, landscape, and land use conditions in the coterminous United States. Vector Borne Zoonotic Dis 2012; 12(8):657-65. doi: 10.1089/vbz.2011.0786 [Crossref]
17. Ahmed A, Dietrich I, LaBeaud AD, Lindsay SW, Musa A, Weaver SC. Risks and challenges of arboviral diseases in Sudan: the urgent need for actions. Viruses 2020; 12(1):81. doi: 10.3390/v12010081 [Crossref]
18. Elduma AH, Osman WM. Dengue and hepatitis E virus infection in pregnant women in Eastern Sudan, a challenge for diagnosis in an endemic area. Pan Afr Med J 2014; 19:391. doi: 10.11604/pamj.2014.19.391.5439 [Crossref]
19. McCarthy MC, Haberberger RL, Salib AW, Soliman BA, El-Tigani A, Khalid IO. Evaluation of arthropod-borne viruses and other infectious disease pathogens as the causes of febrile illnesses in the Khartoum province of Sudan. J Med Virol 1996; 48(2):141-6. doi: 10.1002/(sici)10969071(199602)48:2<141::aid-jmv4>3.0.co;2-9 [Crossref]
20. Ahmed SS, Soghaier MA, Mohammed S, Khogali HS, Osman MM, Abdalla AM. Concomitant outbreaks of yellow fever and hepatitis E virus in Darfur States, Sudan, 2012. J Infect Dev Ctries 2016; 10(1):24-9. doi: 10.3855/jidc.6342 [Crossref]
21. Markoff L. Yellow fever outbreak in Sudan. N Engl J Med 2013; 368(8):689-91. doi: 10.1056/NEJMp1300772 [Crossref]
22. Schiuma M, Pezzati L, Ballone E, Borghi B, Osio M, Mattavelli D. Case report: a fatal case of West Nile virus meningoencephalomyelitis in a woman with systemic lupus erythematosus initially misdiagnosed as SARS-CoV-2 infection. Am J Trop Med Hyg 2021; 104(5):1716-8. doi: 10.4269/ajtmh.21-0041 [Crossref]
23. Eppes C, Rac M, Dunn J, Versalovic J, Murray KO, Suter MA. Testing for Zika virus infection in pregnancy: key concepts to deal with an emerging epidemic. Am J Obstet Gynecol 2017; 216(3):209-25. doi: 10.1016/j.ajog.2017.01.020 [Crossref]
24. Dick GW, Kitchen SF, Haddow AJ. Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg 1952; 46(5):509-20. doi: 10.1016/0035-9203(52)90042-4 [Crossref]
25. Petersen LR, Jamieson DJ, Powers AM, Honein MA. Zika virus. N Engl J Med 2016; 374(16):1552-63. doi: 10.1056/NEJMra1602113 [Crossref]
26. Macnamara FN. Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria. Trans R Soc Trop Med Hyg 1954; 48(2):139-45. doi: 10.1016/0035-9203(54)90006-1 [Crossref]
27. Paixão ES, Barreto F, da Glória Teixeira M, da Conceição N Costa M , Rodrigues LC. History, epidemiology, and clinical manifestations of Zika: a systematic review. Am J Public Health 2016; 106(4):606-12. doi: 10.2105/ajph.2016.303112 [Crossref]
28. Cao-Lormeau VM, Roche C, Teissier A, Robin E, Berry AL, Mallet HP. Zika virus, French polynesia, South Pacific, 2013. Emerg Infect Dis 2014; 20(6):1085-6. doi: 10.3201/eid2006.140138 [Crossref]
29. Dutra HL, Caragata EP, Moreira LA. The re-emerging arboviral threat: hidden enemies: the emergence of obscure arboviral diseases, and the potential use of Wolbachia in their control. Bioessays 2017; 39(2). doi: 10.1002/bies.201600175 [Crossref]
30. Ali S, Gugliemini O, Harber S, Harrison A, Houle L, Ivory J. Environmental and social change drive the explosive emergence of Zika virus in the Americas. PLoS Negl Trop Dis 2017; 11(2):e0005135. doi: 10.1371/journal.pntd.0005135 [Crossref]
31. Asad H, Carpenter DO. Effects of climate change on the spread of Zika virus: a public health threat. Rev Environ Health 2018; 33(1):31-42. doi: 10.1515/reveh-2017-0042 [Crossref]
32. Oidtman RJ, España G, Perkins TA. Co-circulation and misdiagnosis led to underestimation of the 2015-2017 Zika epidemic in the Americas. PLoS Negl Trop Dis 2021; 15(3):e0009208. doi: 10.1371/journal.pntd.0009208 [Crossref]
33. Higgs S, Vanlandingham D. Chikungunya virus and its mosquito vectors. Vector Borne Zoonotic Dis 2015; 15(4):231-40. doi: 10.1089/vbz.2014.1745 [Crossref]
34. Charrel RN, de Lamballerie X, Raoult D. Chikungunya outbreaks--the globalization of vectorborne diseases. N Engl J Med 2007; 356(8):769-71. doi: 10.1056/NEJMp078013 [Crossref]
35. Weaver SC, Forrester NL. Chikungunya: evolutionary history and recent epidemic spread. Antiviral Res 2015; 120:32-9. doi: 10.1016/j.antiviral.2015.04.016 [Crossref]
36. Powers AM. Overview of emerging arboviruses. Future Virol 2009; 4(4):391-401. doi: 10.2217/fvl.09.19 [Crossref]
37. Caglioti C, Lalle E, Castilletti C, Carletti F, Capobianchi MR, Bordi L. Chikungunya virus infection: an overview. New Microbiol 2013; 36(3):211-27.
38. Tajudeen YA, Oladunjoye IO, Adebayo AO, Adebisi YA. The need to adopt planetary health approach in understanding the potential influence of climate change and biodiversity loss on zoonotic diseases outbreaks. Public Health in Practice 2021; 2:100095. doi: 10.1016/j.puhip.2021.100095 [Crossref]
39. Naicker PR. The impact of climate change and other factors on zoonotic diseases. Arch Clin Microbiol 2011; 2(2):1-6.
40. Roiz D, Boussès P, Simard F, Paupy C, Fontenille D. Autochthonous chikungunya transmission and extreme climate events in southern France. PLoS Negl Trop Dis 2015; 9(6):e0003854. doi: 10.1371/journal.pntd.0003854 [Crossref]
41. Godaert L, Bartholet S, Gazeuse Y, Brouste Y, Najioullah F, Kanagaratnam L. Misdiagnosis of chikungunya virus infection: comparison of old and younger adults. J Am Geriatr Soc 2018; 66(9):1768-72. doi: 10.1111/jgs.15492 [Crossref]
42. Beltrán-Silva SL, Chacón-Hernández SS, Moreno-Palacios E, Pereyra-Molina JÁ. Clinical and differential diagnosis: dengue, chikungunya and Zika. Rev Med Hosp Gen (Mex) 2018; 81(3):146-53. doi: 10.1016/j.hgmx.2016.09.011 [Crossref]
43. Erlanger TE, Weiss S, Keiser J, Utzinger J, Wiedenmayer K. Past, present, and future of Japanese encephalitis. Emerg Infect Dis 2009; 15(1):1-7. doi: 10.3201/eid1501.080311 [Crossref]
44. Rosen L. The natural history of Japanese encephalitis virus. Annu Rev Microbiol 1986; 40:395-414. doi: 10.1146/annurev.mi.40.100186.002143 [Crossref]
45. Yun SI, Lee YM. Japanese encephalitis virus: molecular biology and vaccine development. In: Kalitzky M, Borowski P, eds. Molecular Biology of the Flavivirus. Norwich, United Kingdom: Horizon Scientific Press; 2006. p. 225-71.
46. Endy TP, Nisalak A. Japanese encephalitis virus: ecology and epidemiology. Curr Top Microbiol Immunol 2002; 267:11-48. doi: 10.1007/978-3-642-59403-8_2 [Crossref]
47. Yun SI, Lee YM. Japanese encephalitis: the virus and vaccines. Hum Vaccin Immunother 2014; 10(2):263-79. doi: 10.4161/hv.26902 [Crossref]
48. Preziuso S, Mari S, Mariotti F, Rossi G. Detection of Japanese encephalitis virus in bone marrow of healthy young wild birds collected in 1997-2000 in Central Italy. Zoonoses Public Health 2018; 65(7):798-804. doi: 10.1111/zph.12501 [Crossref]
49. Hsu SM, Yen AM, Chen TH. The impact of climate on Japanese encephalitis. Epidemiol Infect 2008; 136(7):980-7. doi: 10.1017/s0950268807009454 [Crossref]
50. Xie YH, Yang JY, Tan Y, Lin M, Bi FY, Wu XH. Clinical features and evaluation of clinical diagnosis of viral encephalitis. Disease Surveillance 2012; 27(4):256-62. doi: 10.3784/j.issn.1003-9961.2012.4.003 [Crossref]
51. World Health Organization. Vaccines and vaccination against yellow fever. WHO position paper -- June 2013. Wkly Epidemiol Rec 2013; 88(27):269-83.
52. WHO. Disease Outbreak News: Yellow Fever – Brazil [Internet]. 6 p. Available from: https://reliefweb.int/sites/reliefweb.int/files/resources/WHO_Brazil_18Apr2019.pdf. Accessed June 30, 2021.
53. Hamer DH, Angelo K, Caumes E, van Genderen PJJ, Florescu SA, Popescu CP. Fatal yellow fever in travelers to Brazil, 2018. MMWR Morb Mortal Wkly Rep 2018; 67(11):340-1. doi: 10.15585/mmwr.mm6711e1 [Crossref]
54. Faria NR, Kraemer MUG, Hill SC, Goes de Jesus J, Aguiar RS, Iani FCM. Genomic and epidemiological monitoring of yellow fever virus transmission potential. Science 2018; 361(6405):894-9. doi: 10.1126/science.aat7115 [Crossref]
55. Chen LH, Wilson ME. Yellow fever control: current epidemiology and vaccination strategies. Trop Dis Travel Med Vaccines 2020; 6:1. doi: 10.1186/s40794-020-0101-0 [Crossref]
56. Gaythorpe KA, Hamlet A, Cibrelus L, Garske T, Ferguson NM. The effect of climate change on yellow fever disease burden in Africa. Elife 2020; 9:e55619. doi: 10.7554/eLife.55619 [Crossref]
57. Hamrick PN, Aldighieri S, Machado G, Leonel DG, Vilca LM, Uriona S. Geographic patterns and environmental factors associated with human yellow fever presence in the Americas. PLoS Negl Trop Dis 2017; 11(9):e0005897. doi: 10.1371/journal.pntd.0005897 [Crossref]
58. Hamlet A, Jean K, Perea W, Yactayo S, Biey J, Van Kerkhove M. The seasonal influence of climate and environment on yellow fever transmission across Africa. PLoS Negl Trop Dis 2018; 12(3):e0006284. doi: 10.1371/journal.pntd.0006284 [Crossref]
59. Tchuandom SB, Tchadji JC, Tchouangueu TF, Biloa MZ, Atabonkeng EP, Fumba MIM. A cross-sectional study of acute dengue infection in paediatric clinics in Cameroon. BMC Public Health 2019; 19(1):958. doi: 10.1186/s12889-019-7252-9 [Crossref]
60. Horton R, Lo S. Planetary health: a new science for exceptional action. Lancet 2015; 386(10007):1921-2. doi: 10.1016/s0140-6736(15)61038-8 [Crossref]
61. World Health Organization—Regional Committee for Africa. Framework for the implementation of the global vector control response in the WHO African region. Available from: https://apps.who.int/iris/handle/10665/331541. Accessed August 2, 2021.
62. Wilder-Smith A, Gubler DJ, Weaver SC, Monath TP, Heymann DL, Scott TW. Epidemic arboviral diseases: priorities for research and public health. Lancet Infect Dis 2017; 17(3):e101-e6. doi: 10.1016/s1473-3099(16)30518-7 [Crossref]
63. Ahmed A, Ali Y, Mohamed NS. Arboviral diseases: the emergence of a major yet ignored public health threat in Africa. Lancet Planet Health 2020; 4(12):e555. doi: 10.1016/s2542-5196(20)30269-2 [Crossref]
64. Chen R, Vasilakis N. Dengue--quo tu et quo vadis?. Viruses 2011; 3(9):1562-608. doi: 10.3390/v3091562 [Crossref]
65. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, Gubler DJ. Dengue: a continuing global threat. Nat Rev Microbiol 2010; 8(12 Suppl):S7-16. doi: 10.1038/nrmicro2460 [Crossref]
66. San Martín JL, Brathwaite O, Zambrano B, Solórzano JO, Bouckenooghe A, Dayan GH. The epidemiology of dengue in the americas over the last three decades: a worrisome reality. Am J Trop Med Hyg 2010; 82(1):128-35. doi: 10.4269/ajtmh.2010.09-0346 [Crossref]
67. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL. The global distribution and burden of dengue. Nature 2013; 496(7446):504-7. doi: 10.1038/nature12060 [Crossref]
68. Brady OJ, Gething PW, Bhatt S, Messina JP, Brownstein JS, Hoen AG. Refining the global spatial limits of dengue virus transmission by evidence-based consensus. PLoS Negl Trop Dis 2012; 6(8):e1760. doi: 10.1371/journal.pntd.0001760 [Crossref]
69. Linares EM, Pannuti CS, Kubota LT, Thalhammer S. Immunospot assay based on fluorescent nanoparticles for dengue fever detection. Biosens Bioelectron 2013; 41:180-5. doi: 10.1016/j.bios.2012.08.005 [Crossref]
70. Malavige GN, Fernando S, Fernando DJ, Seneviratne SL. Dengue viral infections. Postgrad Med J 2004; 80(948):588-601. doi: 10.1136/pgmj.2004.019638 [Crossref]
71. Stanaway JD, Shepard DS, Undurraga EA, Halasa YA, Coffeng LE, Brady OJ. The global burden of dengue: an analysis from the Global Burden of Disease Study 2013. Lancet Infect Dis 2016; 16(6):712-23. doi: 10.1016/s1473-3099(16)00026-8 [Crossref]
72. Gupta N, Srivastava S, Jain A, Chaturvedi UC. Dengue in India. Indian J Med Res 2012; 136(3):373-90.
73. Eckerle I, Kapaun A, Junghanss T, Schnitzler P, Drosten C, Jänisch T. Dengue virus serotype 3 infection in traveler returning from West Africa to Germany. Emerg Infect Dis 2015; 21(1):175-7. doi: 10.3201/eid2101.141145 [Crossref]
74. Jaenisch T, Junghanss T, Wills B, Brady OJ, Eckerle I, Farlow A. Dengue expansion in Africa-not recognized or not happening?. Emerg Infect Dis 2014; 20(10). doi: 10.3201/eid2010.140487 [Crossref]
75. Amarasinghe A, Kuritsk JN, Letson GW, Margolis HS. Dengue virus infection in Africa. Emerg Infect Dis 2011; 17(8):1349-54. doi: 10.3201/eid1708.101515 [Crossref]
76. Marchi S, Trombetta CM, Montomoli E. Emerging and re-emerging arboviral diseases as a global health problem. In: Majumder MAA, ed. Public Health. London, UK: IntechOpen; 2018. p. 25-46. 10.5772/intechopen.77382.
77. Tuladhar R, Singh A, Varma A, Choudhary DK. Climatic factors influencing dengue incidence in an epidemic area of Nepal. BMC Res Notes 2019; 12(1):131. doi: 10.1186/s13104-019-4185-4 [Crossref]
78. Wilder-Smith A, Gubler DJ. Geographic expansion of dengue: the impact of international travel. Med Clin North Am 2008; 92(6):1377-90. doi: 10.1016/j.mcna.2008.07.002 [Crossref]
79. Tajudeen YA. Anthropocene-An Era with Evil Six Threats Changing the Fate of Biodi-versity: Emerging and Re-emerging Aboviruses Calls for Holistic Approach. J Infect Dis Epidemiol 2021; 7(6):212. doi: 10.23937/2474-3658/1510212 [Crossref]
80. Otto AM. Pediatric News—Fatal U.S dengue fever case misdiagnosed as West Nile Virus. Available from: https://www.mdedge.com/pediatrics/article/80011/infectious-diseases/fatal-us-dengue-fever-case-misdiagnosed-west-nile-virus. Accessed July 1, 2021.
81. Ahmed A. Urgent call for a global enforcement of the public sharing of health emergencies data: lesson learned from serious arboviral disease epidemics in Sudan. Int Health 2020; 12(4):238-40. doi: 10.1093/inthealth/ihz122 [Crossref]
82. Elduma A. Yellow fever outbreak in Darfur Region-Sudan 2012, a response to health crisis. Glob J Epidemiol Public Health 2014; 1:57-61. doi: 10.12974/2313-0946.2014.01.02.4 [Crossref]
83. Soghaier MA, Hagar A, Abbas MA, Elmangory MM, Eltahir KM, Sall AA. Yellow fever outbreak in Darfur, Sudan in October 2012; the initial outbreak investigation report. J Infect Public Health 2013; 6(5):370-6. doi: 10.1016/j.jiph.2013.04.007 [Crossref]
84. Weetman D, Kamgang B, Badolo A, Moyes CL, Shearer FM, Coulibaly M. Aedes mosquitoes and Aedes-borne arboviruses in Africa: current and future threats. Int J Environ Res Public Health 2018; 15(2):220. doi: 10.3390/ijerph15020220 [Crossref]
85. Bai L, Morton LC, Liu Q. Climate change and mosquito-borne diseases in China: a review. Global Health 2013; 9:10. doi: 10.1186/1744-8603-9-10 [Crossref]
86. Bi P, Tong S, Donald K, Parton KA, Ni J. Climate variability and transmission of Japanese encephalitis in eastern China. Vector Borne Zoonotic Dis 2003; 3(3):111-5. doi: 10.1089/153036603768395807 [Crossref]
87. Bai Y, Xu Z, Zhang J, Mao D, Luo C, He Y. Regional impact of climate on Japanese encephalitis in areas located near the three gorges dam. PLoS One 2014; 9(1):e84326. doi: 10.1371/journal.pone.0084326 [Crossref]
88. Murty US, Rao MS, Arunachalam N. The effects of climatic factors on the distribution and abundance of Japanese encephalitis vectors in Kurnool district of Andhra Pradesh, India. J Vector Borne Dis 2010; 47(1):26-32.
89. Borah J, Dutta P, Khan SA, Mahanta J. Association of weather and anthropogenic factors for transmission of Japanese encephalitis in an endemic area of India. Ecohealth 2013; 10(2):129-36. doi: 10.1007/s10393-013-0849-z [Crossref]
90. Miller RH, Masuoka P, Klein TA, Kim HC, Somer T, Grieco J. Ecological niche modeling to estimate the distribution of Japanese encephalitis virus in Asia. PLoS Negl Trop Dis 2012; 6(6):e1678. doi: 10.1371/journal.pntd.0001678 [Crossref]
91. Bi P, Zhang Y, Parton KA. Weather variables and Japanese encephalitis in the metropolitan area of Jinan city, China. J Infect 2007; 55(6):551-6. doi: 10.1016/j.jinf.2007.07.004 [Crossref]
92. Misra UK, Kalita J. Overview: Japanese encephalitis. Prog Neurobiol 2010; 91(2):108-20. doi: 10.1016/j.pneurobio.2010.01.008 [Crossref]
93. Paz S, Malkinson D, Green MS, Tsioni G, Papa A, Danis K. Permissive summer temperatures of the 2010 European West Nile fever upsurge. PLoS One 2013; 8(2):e56398. doi: 10.1371/journal.pone.0056398 [Crossref]
94. Vogels CB, Fros JJ, Göertz GP, Pijlman GP, Koenraadt CJ. Vector competence of northern European Culex pipiens biotypes and hybrids for West Nile virus is differentially affected by temperature. Parasit Vectors 2016; 9(1):393. doi: 10.1186/s13071-016-1677-0 [Crossref]
95. Kilpatrick AM, Meola MA, Moudy RM, Kramer LD. Temperature, viral genetics, and the transmission of West Nile virus by Culex pipiens mosquitoes. PLoS Pathog 2008; 4(6):e1000092. doi: 10.1371/journal.ppat.1000092 [Crossref]
96. Anyamba A, Linthicum KJ, Tucker CJ. Climate-disease connections: Rift Valley fever in Kenya. Cad Saude Publica 2001; 17 Suppl:133-40. doi: 10.1590/s0102-311x2001000700022 [Crossref]
97. Balkhy HH, Memish ZA. Rift Valley fever: an uninvited zoonosis in the Arabian Peninsula. Int J Antimicrob Agents 2003; 21(2):153-7. doi: 10.1016/s0924-8579(02)00295-9 [Crossref]
98. Bicout DJ, Sabatier P. Mapping Rift Valley fever vectors and prevalence using rainfall variations. Vector Borne Zoonotic Dis 2004; 4(1):33-42. doi: 10.1089/153036604773082979 [Crossref]
99. Elfadil AA, Hasab-Allah KA, Dafa-Allah OM. Factors associated with Rift Valley fever in south-west Saudi Arabia. Rev Sci Tech 2006; 25(3):1137-45.
100. Caminade C, Ndione JA, Diallo M, MacLeod DA, Faye O, Ba Y. Rift Valley fever outbreaks in Mauritania and related environmental conditions. Int J Environ Res Public Health 2014; 11(1):903-18. doi: 10.3390/ijerph110100903 [Crossref]
101. Clements AC, Pfeiffer DU, Martin V, Pittliglio C, Best N, Thiongane Y. Spatial risk assessment of Rift Valley fever in Senegal. Vector Borne Zoonotic Dis 2007; 7(2):203-16. doi: 10.1089/vbz.2006.0600 [Crossref]
102. Saluzzo JF, Digoutte JP, Chartier C, Martinez D, Bada R. Focus of Rift Valley fever virus transmission in southern Mauritania. Lancet 1987; 1(8531):504. doi: 10.1016/s0140-6736(87)92110-6 [Crossref]
103. Zeller HG, Akakpo AJ, Ba MM. Rift Valley fever epizootic in small ruminants in southern Mauritania (October 1993): risk of extensive outbreaks. Ann Soc Belg Med Trop 1995; 75(2):135-40.
104. Heinrich N, Saathoff E, Weller N, Clowes P, Kroidl I, Ntinginya E. High seroprevalence of Rift Valley fever and evidence for endemic circulation in Mbeya region, Tanzania, in a cross-sectional study. PLoS Negl Trop Dis 2012; 6(3):e1557. doi: 10.1371/journal.pntd.0001557 [Crossref]
105. Métras R, Jewell C, Porphyre T, Thompson PN, Pfeiffer DU, Collins LM. Risk factors associated with Rift Valley fever epidemics in South Africa in 2008-11. Sci Rep 2015; 5:9492. doi: 10.1038/srep09492 [Crossref]
106. Ushijima Y, Abe H, Nguema Ondo G, Bikangui R, Massinga Loembé M, Zadeh VR. Surveillance of the major pathogenic arboviruses of public health concern in Gabon, Central Africa: increased risk of West Nile virus and dengue virus infections. BMC Infect Dis 2021; 21(1):265. doi: 10.1186/s12879-021-05960-9 [Crossref]
107. Brubaker JF, Turell MJ. Effect of environmental temperature on the susceptibility of Culex pipiens (Diptera: Culicidae) to Rift Valley fever virus. J Med Entomol 1998; 35(6):918-21. doi: 10.1093/jmedent/35.6.918 [Crossref]
108. Turell MJ. Effect of environmental temperature on the vector competence of Aedes fowleri for Rift Valley fever virus. Res Virol 1989; 140(2):147-54. doi: 10.1016/s0923-2516(89)80092-5 [Crossref]
109. United Nations Department of Economic and Social Affairs (DESA). World Population Prospects, the 2012 Revision. New York: Population division of the department of economic and social affairs; 2013. p. 18.
110. Liang G, Gao X, Gould EA. Factors responsible for the emergence of arboviruses; strategies, challenges and limitations for their control. Emerg Microbes Infect 2015; 4(3):e18. doi: 10.1038/emi.2015.18 [Crossref]
111. Karabatsos N. International Catalogue of Arthropod-Borne Viruses. 3rd ed. San Antonio, TX: American Society for Tropical Medicine and Hygiene. 1985. p. 1147.
112. Adelman ZN, Miller DM, Myles KM. Bed bugs and infectious disease: a case for the arboviruses. PLoS Pathog 2013; 9(8):e1003462. doi: 10.1371/journal.ppat.1003462 [Crossref]
113. King AM, Adams MJ, Carstens EB, Lefkowitz EJ. Virus Taxonomy: Ninth Report of the International Committee on Taxonomy of Viruses. London: Elsevier/Academic Press; 2021. p. 1462.
114. Kuno G, Chang GJ. Biological transmission of arboviruses: reexamination of and new insights into components, mechanisms, and unique traits as well as their evolutionary trends. Clin Microbiol Rev 2005; 18(4):608-37. doi: 10.1128/cmr.18.4.608-637.2005 [Crossref]
115. Kilpatrick AM, Kramer LD, Jones MJ, Marra PP, Daszak P. West Nile virus epidemics in North America are driven by shifts in mosquito feeding behavior. PLoS Biol 2006; 4(4):e82. doi: 10.1371/journal.pbio.0040082 [Crossref]
116. Gupta E, Mohan S, Bajpai M, Choudhary A, Singh G. Circulation of dengue virus-1 (DENV-1) serotype in Delhi, during 2010-11 after dengue virus-3 (DENV-3) predominance: a single centre hospital-based study. J Vector Borne Dis 2012; 49(2):82-5.
117. Roehr B. US hit by massive West Nile virus outbreak centred around Texas. BMJ 2012; 345:e5633. doi: 10.1136/bmj.e5633 [Crossref]
118. Petersen LR, Roehrig JT. West Nile virus: a reemerging global pathogen. Emerg Infect Dis 2001; 7(4):611-4. doi: 10.3201/eid0704.010401 [Crossref]
119. Kilpatrick AM. Globalization, land use, and the invasion of West Nile virus. Science 2011; 334(6054):323-7. doi: 10.1126/science.1201010 [Crossref]
120. Erlanger TE, Weiss S, Keiser J, Utzinger J, Wiedenmayer K. Past, present, and future of Japanese encephalitis. Emerg Infect Dis 2009; 15(1):1-7. doi: 10.3201/eid1501.080311 [Crossref]
121. Lindahl J, Chirico J, Boqvist S, Thu HTV, Magnusson U. Occurrence of Japanese encephalitis virus mosquito vectors in relation to urban pig holdings. Am J Trop Med Hyg 2012; 87(6):1076-82. doi: 10.4269/ajtmh.2012.12-0315 [Crossref]
122. van den Hurk AF, Ritchie SA, Mackenzie JS. Ecology and geographical expansion of Japanese encephalitis virus. Annu Rev Entomol 2009; 54:17-35. doi: 10.1146/annurev.ento.54.110807.090510 [Crossref]
123. Girard M, Nelson CB, Picot V, Gubler DJ. Arboviruses: a global public health threat. Vaccine 2020; 38(24):3989-94. doi: 10.1016/j.vaccine.2020.04.011 [Crossref]
124. Lorenz C, Azevedo TS, Virginio F, Aguiar BS, Chiaravalloti-Neto F, Suesdek L. Impact of environmental factors on neglected emerging arboviral diseases. PLoS Negl Trop Dis 2017; 11(9):e0005959. doi: 10.1371/journal.pntd.0005959 [Crossref]
125. Causa R, Ochoa-Díaz-López H, Dor A, Rodríguez-León F, Solís-Hernández R, Pacheco-Soriano AL. Emerging arboviruses (dengue, chikungunya, and Zika) in Southeastern Mexico: influence of socio-environmental determinants on knowledge and practices. Cad Saude Publica 2020; 36(6):e00110519. doi: 10.1590/0102-311x00110519 [Crossref]
126. Lima EP, Goulart MO, Rolim Neto ML. Meta-analysis of studies on chemical, physical and biological agents in the control of Aedes aegypti. BMC Public Health 2015; 15:858. doi: 10.1186/s12889-015-2199-y [Crossref]
127. Centers for Disease Control and Prevention (CDC). Zika Virus Statistics and Maps. Available from: www.cdc.gov/zika/reporting/index.html. Accessed April 12, 2021.
128. Zika: the continuing threat. Bull World Health Organ 2019; 97(1):6-7. doi: 10.2471/blt.19.020119 [Crossref]
129. Lerner H, Berg C. A Comparison of Three Holistic Approaches to Health: One Health, EcoHealth, and Planetary Health. Front Vet Sci 2017; 4:163. doi: 10.3389/fvets.2017.00163 [Crossref]
130. Rocklöv J, Tozan Y. Climate change and the rising infectiousness of dengue. Emerg Top Life Sci 2019; 3(2):133-42. doi: 10.1042/etls20180123 [Crossref]
131. Iwamura T, Guzman-Holst A, Murray KA. Accelerating invasion potential of disease vector Aedes aegypti under climate change. Nat Commun 2020; 11(1):2130. doi: 10.1038/s41467-020-16010-4 [Crossref]
132. Whitmee S, Haines A, Beyrer C, Boltz F, Capon AG, de Souza Dias BF. Safeguarding human health in the Anthropocene epoch: report of The Rockefeller Foundation-Lancet Commission on planetary health. Lancet 2015; 386(10007):1973-2028. doi: 10.1016/s0140-6736(15)60901-1 [Crossref]
133. Pongsiri MJ, Bickersteth S, Colón C, DeFries R, Dhaliwal M, Georgeson L. Planetary health: from concept to decisive action. Lancet Planet Health 2019; 3(10):e402-e4. doi: 10.1016/s2542-5196(19)30190-1 [Crossref]
134. Singer M. The spread of Zika and the potential for global arbovirus syndemics. Glob Public Health 2017; 12(1):1-18. doi: 10.1080/17441692.2016.1225112 [Crossref]
135. Oladunjoye IO, Adebayo AO, Odumosu OO, Adebisi YA. The African continent needs to prioritise planetary health. Public Health in Pract 2020; 2(1):100071. doi: 10.1016/j.puhip.2020.100071 [Crossref]
136. Centre for Disease Control and Prevention (CDC). Department of Health and Human Services, United States of America. One Health Basics—One Health. Available from: https://www.cdc.gov/onehealth/basics/index.html#:~:text = One%20Health%20is%20a%20collaborative,plants%2C%20and%20their%20shared%20environment. Accessed April 12, 2021.
137. Dente MG, Riccardo F, Nacca G, Ranghiasci A, Manuguerra JC, Escadafal C. Strengthening integrated surveillance for arboviruses in the Mediterranean and Black Sea regions in the framework of the One Health approach. Quaderni Della Società Italiana Di Medicina Tropicale E Salute Globale 2016; 1:41-8.
138. Bresalier M, Cassidy A, Woods A. One Health in history. In: Zinsstag J, Schelling E, Waltner-Toews D, Whittaker M, Tanner M, eds. One Health: The Theory and Practice of Integrated Health Approaches. Wallingford: CABI; 2015. p. 1-15. 10.1079/9781789242577.0001
139. Parkes M, Waltner-Toews D, Horwitz P. Ecohealth. In: Michalos AC, ed. Encyclopedia of Quality of Life and Well-Being Research. Dordrecht: Springer; 2014. 10.1007/978-94-007-0753-5_4172
140. Waltner-Toews D. Eco-Health: a primer for veterinarians. Can Vet J 2009; 50(5):519-21.
141. McGraw EA, O’Neill SL. Beyond insecticides: new thinking on an ancient problem. Nat Rev Microbiol 2013; 11(3):181-93. doi: 10.1038/nrmicro2968 [Crossref]
142. Gantz VM, Jasinskiene N, Tatarenkova O, Fazekas A, Macias VM, Bier E. Highly efficient Cas9-mediated gene drive for population modification of the malaria vector mosquito Anopheles stephensi. Proc Natl Acad Sci U S A 2015; 112(49):E6736-43. doi: 10.1073/pnas.1521077112 [Crossref]